Skip to main content

News

November 11, 2024

SARomics Biostructures and Vipergen collaborate to offer enhanced drug discovery services

Aurigene Pharmaceutical Services Ltd., and Vipergen announce a strategic partnership for offering DNA encoded library (DEL) screening and integrated drug discovery services.

Vipergen and LEO Pharma Partner for DNA Encoded Library (DEL)-Based Drug Discovery for Dermatology Indications

Vipergen Establishes DNA Encoded Library (DEL)-Based Drug Discovery Partnership with Theseus Pharmaceuticals Focused on Targeted Cancer Therapies

December 21, 2021

Vipergen Establishes Research Partnership with Bayer to Discover Novel Compounds for Pharmaceuticals and More Sustainable Crop Protection Solutions

November 23, 2021

Vipergen Establishes Research Partnership with Aligos Therapeutics Focused on DNA Encoded Library (DEL)-Based Drug Discovery for Viral Infections and Liver Diseases

November 15, 2021

Vipergen Establishes Research Partnership with ALK Focused on DNA-Encoded Library (DEL)-Based Drug Discovery for Allergy Immunotherapies

October 21, 2021

BASF and Vipergen accelerate targeted research and development of sustainable crop protection products

September 14, 2021

Vipergen Establishes Research Partnership with PhoreMost Focused on DNA Encoded Library (DEL)-Based Drug Discovery

Vipergen Establishes Partnership with Anavo Therapeutics to Support Phosphatase-Targeted Discovery Programs

Vipergen strengthens leadership by appointing Dr Leif Kongskov Larsen as Director of Biology and promoting Dr Allan Beck Christensen to Director of Screening Technologies

February 17, 2021

Vipergen Publishes First Technology for Screening DNA-Encoded Small-Molecule Libraries (DELs) Inside Living Cells

December 1, 2020

Casma Therapeutics and Vipergen Enter Into Drug Discovery Agreement

November 6, 2020

Commercial release of the first technology for DEL screening inside a living cell

December 20, 2016

Vipergen enters into multi-target drug discovery agreement with Merck

Vipergen enters into multi-target drug discovery agreement with Daiichi Sankyo

Vipergen enters into multi-target drug discovery agreement with Gilead

December 21, 2015

Vipergen enters into multi-target collaboration with Europes largest biopharmaceutical company

December 18, 2015

Vipergen enters into multi-target drug discovery agreement with Amgen